The global rapid medical diagnostic kits market size is predicted to reach USD 23.04 billion by 2027
Rapid medical diagnostic kits are also known as immediate test kits which are designed to provide instant access to diagnose the patients or the individual with several types of diseases. The rapid medical diagnostic kits can be accessed 24/7 and help to deliver the immediate course of action during an emergency period. The rapid medical diagnostic kits are also cost-effective and easy to access anywhere.
Recent developments in the global market include the new test launches such as SARS-CoV-2 rapid antigen test, 2019-nCoV IgG/IgM test kit, On-Call Sure Platform, Afinion HbA1c Dx, TruQuick, etc. The launches are associated with the diagnosis of diseases such as cardiac disorder, diabetes, infectious disease, and others, which further leads to drive the market growth.
Share this article
Share this article
NEW YORK, Dec. 14, 2020 /PRNewswire/ The global rapid medical diagnostic kits market size is predicted to reach
USD 23.04 billion by 2027 according to a new study conducted by
Polaris Market Research. The market is anticipated to register a CAGR 4.2% From 2020 – 2027 Increasing cases of infectious diseases, cardiovascular diseases, and chronic diseases are primary factors responsible for the surge in demand for the global rapid medical diagnostic kits market. A rise in awareness among consumers regarding the adoption of such medical kits is anticipated to fuel the growth of the global market. The rising investment by public-private institutions, new product developments, and awareness campaigns by governments are some of the key factors creating new growth avenues for the global rapid medical diagnostic kits market. An increase in the prevalence of